PAGI-SYM (Patient Assessment of Upper Gastroinstestinal Symptoms)
Developed by: Johnson & Johnson (USA)
Objective: To assess symptom severity in patients with dyspepsia, GERD, or gastroparesis.
Copyright: Johnson & Johnson, USA. All rights reserved.
Reference publication: Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, de la Loge C, Trudeau E, Dubois D, Revicki DA. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004 Dec;13(10):1737-49.
Conditions of use:
1. User Agreement:
User is required to complete and sign a User Agreement in which specific conditions required by the copyright owner are detailed.
2. Distribution Fees:
Distribution fees are requested according to the study design and context of use of the questionnaire:
In not-funded academic research (1) and individual clinical practice,
In funded academic research (2): 300 €* per study + an additional 50 €* per language version requested.
In commercial studies (3) involving "for-profit" organizations: 600 €* per study + an additional 250 €* per language version requested.
* excluding VAT
(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.
(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.
(3) Commercial studies (industry, CRO, any for-profit companies).
27 rue de la Villette F - 69003 LYON Tel: +33 4 72 13 65 75 Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.